Is the compound with CAS 56 - 75 - 7 toxic?
As a supplier of the compound with CAS 56 - 75 - 7, I often encounter questions from customers regarding its toxicity. CAS 56 - 75 - 7 corresponds to Chloramphenicol, a well - known broad - spectrum antibiotic. In this blog, I'll delve into the topic of its toxicity based on scientific knowledge and industry experience.
Understanding Chloramphenicol
Chloramphenicol was first isolated from the bacterium Streptomyces venezuelae in 1947. It has a wide range of antibacterial activities against both Gram - positive and Gram - negative bacteria. Its mechanism of action involves inhibiting bacterial protein synthesis by binding to the 50S subunit of the ribosome, thereby preventing the formation of peptide bonds.
Toxicity Profile
Hematological Toxicity
One of the most well - known and serious toxic effects of chloramphenicol is its impact on the hematopoietic system. It can cause two types of hematological toxicity: reversible bone marrow suppression and the rare but often fatal idiosyncratic aplastic anemia.
Reversible bone marrow suppression is dose - related and usually occurs during treatment. It is characterized by a decrease in the production of red blood cells, white blood cells, and platelets. This type of suppression is generally reversible once the drug is discontinued. On the other hand, idiosyncratic aplastic anemia is an unpredictable and often irreversible condition. It can develop weeks or months after chloramphenicol exposure and has a high mortality rate. The exact mechanism behind this idiosyncratic reaction is not fully understood, but it is thought to involve genetic factors and the formation of toxic metabolites.
Gray Baby Syndrome
This is a unique form of toxicity associated with chloramphenicol use in neonates, especially premature infants. Neonates have immature liver function, which impairs their ability to conjugate chloramphenicol with glucuronic acid for elimination. As a result, high levels of the drug accumulate in the body. Infants with gray baby syndrome present with abdominal distension, vomiting, cyanosis, ashen - gray skin color, and circulatory collapse. If not treated promptly, it can be fatal.
Other Toxicities
Chloramphenicol can also cause other side effects, such as gastrointestinal disturbances including nausea, vomiting, and diarrhea. It may also lead to neurological side effects like optic neuritis, peripheral neuritis, and confusion, although these are relatively less common.
Safety Measures and Regulations
Due to its significant toxicity, the use of chloramphenicol is strictly regulated in many countries. In the food industry, it is banned as a veterinary drug in many regions because of the potential for residues in food products to pose a risk to human health. In human medicine, it is usually reserved for severe infections when other antibiotics are ineffective or contraindicated.
When handling chloramphenicol in a laboratory or industrial setting, appropriate safety precautions must be taken. Workers should wear personal protective equipment such as gloves, goggles, and lab coats to prevent skin contact and inhalation of the compound.
Comparison with Other Compounds
It's interesting to compare chloramphenicol with other compounds in the pharmaceutical field. For example, Olmesartan Medoxomil CAS#144689 - 63 - 4 is an angiotensin II receptor blocker used for the treatment of hypertension. Unlike chloramphenicol, its toxicity profile is mainly related to mild side effects such as dizziness, headache, and hypotension, and it does not have the severe hematological toxicity associated with chloramphenicol.
Another compound, Hydrocortisone Acetate CAS#50 - 03 - 3, is a corticosteroid with anti - inflammatory and immunosuppressive properties. Its side effects are related to long - term use and include issues like adrenal suppression, weight gain, and increased susceptibility to infections, which are very different from the toxic effects of chloramphenicol.
D - P - METHYL SULFONE PHENYL ETHYL SERINATE CAS#36983 - 12 - 7 is an intermediate in the synthesis of certain pharmaceuticals. While specific toxicity data may vary depending on its use and handling, it is generally not associated with the same level of well - known and severe toxicities as chloramphenicol.
Our Role as a Supplier
As a supplier of chloramphenicol, we are fully aware of its toxicity and the associated risks. We ensure that all our products are of high quality and meet the relevant safety standards. We provide detailed safety data sheets (SDS) to our customers, which include information on the compound's toxicity, handling procedures, and emergency response measures.
We also work closely with our customers to ensure that they are using chloramphenicol in a safe and appropriate manner. Whether it is for research purposes or in a controlled industrial application, we offer technical support and guidance to minimize the risks associated with its use.
Conclusion
In conclusion, the compound with CAS 56 - 75 - 7, chloramphenicol, is indeed toxic, with well - documented and potentially severe side effects, especially on the hematopoietic system. However, when used in a carefully controlled and informed manner, it can still have its place in certain medical and research applications.
If you are interested in purchasing chloramphenicol for your specific needs, we encourage you to contact us for further discussion. Our team of experts can provide you with more detailed information on the product, its safety, and how it can be used effectively in your projects.
References
- Goodman & Gilman's The Pharmacological Basis of Therapeutics. 13th edition.
- Martindale: The Complete Drug Reference. 38th edition.
- World Health Organization. Guidelines on the use of chloramphenicol in human and veterinary medicine.